A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2004
11/10/2004	EP1474100A2 Cosmetic or dermopharmaceutical compositions which are used to reduce bags and circles under the eyes
11/10/2004	EP1474093A2 Granzyme b inhibitors
11/10/2004	EP1416799A4 Methods and compositions for treating fungal infections
11/10/2004	EP1265570B1 Soluble keratin peptide
11/10/2004	EP1261605B1 Benzoxazole derivatives as tnf and pde iv inhibitors
11/10/2004	EP1246793B1 Substituted aminomethyl-phenyl-cyclohexane derivatives
11/10/2004	CN1545512A Rapamycin dialdehydes
11/10/2004	CN1545509A Piperidine derivatives useful as modulators of chemokine receptor activity
11/10/2004	CN1545417A Novel vaccine for prophylaxis and theraphy in vetirinary and human medicine
11/10/2004	CN1545406A Water-free ubichinon concentrate
11/10/2004	CN1545402A Substance capable of potentiating laminin 5 productivity in epidermal cells and utilization thereof
11/10/2004	CN1544452A Novel macrolides drug 4'-epitope-9alfa-N-R-9alfa-aza homoerythromycin A derivative, synthesis method and uses
11/10/2004	CN1544451A Novel macrolides drug -9-OR-erythromycin A oxime, synthesis method and uses
11/10/2004	CN1544450A Novel macrolides drug 9-deoxidized-9alfa-N-substituted alkane or amide- erythromycin A derivative, synthesis method and uses
11/10/2004	CN1544091A Melanocyte suspension and its preparation for treating leukodermia
11/10/2004	CN1544060A Psoriasis treating medicine
11/10/2004	CN1544059A Preparing method of burn and scald treating medicine
11/10/2004	CN1544039A Fat-reducing speckle-removing cosmetic mixture and its capsule
11/10/2004	CN1544038A Hair darkening and regenerating medicine and its preparation
11/10/2004	CN1544036A Speckle removing and whitening traditional medicinal healthy product and its preparation
11/10/2004	CN1544025A Externally used medicine for treating burns and scalds and its preparation
11/10/2004	CN1544003A Medicine for treating trauma and sores and its preparing process
11/10/2004	CN1544001A Chinese traditional medicine for preventing and treating tinea pedis
11/10/2004	CN1543996A Paste for burns and scalds
11/10/2004	CN1543995A Psoriasis treating ointment
11/10/2004	CN1543985A Nanometer antibiotic human body lubricant
11/10/2004	CN1543983A Wound nursing medicinal composition
11/10/2004	CN1543947A Novel use of indomethacin and its external applied preparation for treating cutaneous pruritus
11/10/2004	CN1543930A Method for making plaster adhesive bandage
11/10/2004	CN1543928A Cosmetics for treating acne acarid and method for producing the same
11/10/2004	CN1174993C VEGI, an inhibitor for angiogenesis and tumor growth
11/10/2004	CN1174984C Carbamoyl tetrahydropyridine derivatives
11/10/2004	CN1174981C Imidazole [1,2-A] pyridine and pyrazole [2,3-a] pyridine derivatives
11/10/2004	CN1174964C Vitamin D3 Analogs
11/10/2004	CN1174956C Aminobenzophenones as inhibitors of IL-1 bata and TNF-alpha
11/10/2004	CN1174766C Chinese medicine beautifying pellet and its compounding process
11/10/2004	CN1174765C Composite Chinese medicine for treating venereal disease and dermatosis and its preparing method
11/10/2004	CN1174751C Method for preventing and curing skid aging
11/10/2004	CN1174734C Shampoo compositions
11/09/2004	US6815557 Tryptase inhibitors
11/09/2004	US6815534 Tissue plasminogen activator-like protease
11/09/2004	US6815465 Heterocyclic compounds inhibiting angiogenesis
11/09/2004	US6815463 For therapy of disease of cellular hyperproliferation in a subject
11/09/2004	US6815460 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors
11/09/2004	US6815438 Heteroaryl-diazabicycloalkanes
11/09/2004	US6815416 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor
11/09/2004	US6814985 Herbal compositions and uses for the treatment of allergic reactions
11/04/2004	WO2004094472A2 Collagen fibrils carrying bioactive heterologous domains and their use in e.g. wound healing
11/04/2004	WO2004094448A1 METHYLATED CpG POLYNUCLEOTIDE
11/04/2004	WO2004094424A1 Nitrogen-containing heterocyclic compounds and use thereof
11/04/2004	WO2004093996A1 Topical sulfacetamide composition and method for treating seborrheic dermatitis
11/04/2004	WO2004093907A2 Therapeutic agents for treating dermatitis, alopecia and itching and transgenic animals for evaluating such therapeutic agents
11/04/2004	WO2004093886A1 Topical formulation of ivermectin for the treatment of dermatological conditions
11/04/2004	WO2004093832A2 Cosmetic or pharmaceutical composition comprising a combination of at least one diacylglycerol and at least one fatty alcohol
11/04/2004	WO2004093781A2 Podophyllotoxin derivatives as igf-1r inhibitors
11/04/2004	WO2004047747A3 Compositions and methods for cell dedifferentiation and tissue regeneration
11/04/2004	WO2003086324A3 Preparation and use of a stable formulation of allosteric effector compounds
11/04/2004	WO2003082867A8 Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents
11/04/2004	WO2003077847A3 Substituted amides
11/04/2004	WO1999029693A8 Imidazonaphthyridines and their use in inducing cytokine biosynthesis
11/04/2004	US20040220408 As anti-proliferative agents, therapy
11/04/2004	US20040220403 For therapy and prophylaxis of Tachykinin-mediated diseases
11/04/2004	US20040220276 Coated granules of allylamine-or benzylamine-anti-mycotics
11/04/2004	US20040220260 efficacious in producing nitric oxide in the skin, the mucous membranes or the scalp; treatment of psoriasis lesions and/or chronic ulcers; i.e. Ascorbyl 2-O-cinnamate
11/04/2004	US20040220244 PHOSPHOLIPASE INHIBITORS; use of inhibitor compositions in mammals to relieve sick conditions accompanied by enhanced PLA(2) activity such as inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease
11/04/2004	US20040220230 transfroming growth factor antagonist; therapy for urogenital disorders, cardiovascular disorders
11/04/2004	US20040220204 mixture of fatty ester, alkylene carbonate, butylene glycol, diethylene glycol, monoalkyl ether and thickeners
11/04/2004	US20040220175 (Pyrido/thieno) - [f] - oxazepine-5-one derivatives
11/04/2004	US20040220171 anticoagulants; immunomoderators; antiinflammatory agents
11/04/2004	US20040220147 Antiarrhythmia agents; liver disorders; skin disorders
11/04/2004	US20040220146 Methods and compositions for treating fungal infections
11/04/2004	US20040220133 Composition and method for inhibiting platelet aggregation
11/04/2004	US20040220112 administering 2-(N-Methylsulfonamido-2-aminophenyl)-N-methyl-N-[(1S)-1-phenyl-2-(1-pyrrolidinyl)ethyl]acetamide as an anti-pruritic agent; antihyperalgesics; analgesics; central nervous system side effect reduction
11/04/2004	US20040220111 administering polypeptide in mixturte with carrier; topical applying surface of body; wound healing agents; tissue repair
11/04/2004	US20040220092 G-protein coupled receptors
11/04/2004	US20040219640 Polypeptides homologous to VEGFand BMPI
11/04/2004	US20040219635 Degradation resistant antihypoxic agents for use in treatment and prevention of hypoxia and ischemic related tissue damage
11/04/2004	US20040219230 Compositions for preparing external carbon dioxide agents
11/04/2004	US20040219202 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety
11/04/2004	US20040219148 comprising an agent that targets an interleukin-15 receptor and a second agent that inhibits a costimulatory signal transmitted between a T cell and an antigen-presenting cell; treating autoimmune diseases, AIDS, vascular injuries or organ, tissue or cell transplant recipients
11/04/2004	US20040219144 administering an anti-human NGF monoclonal antibody capable of binding hNGF with an affinity in the nanomolar range, and inhibiting the binding of hNGF to human TrkA (hTrkA) in vivo, wherein said antibody has no significant adverse effect on the immune system
11/04/2004	US20040219123 recrystallization-resistant; also comprising a glycolic or hydroglycolic dispersed hydrophilic phase, a lipophilic continuous phase and an emulsifier having an HLB ranging from 2 to 7; preventing/treating the chronological or actinic skin aging and atrophy of the skin or mucous membranes
11/04/2004	US20040219114 Cream for treatment of skin injured by the sun
11/03/2004	EP1473300A1 Pharmaceutical composition for the treatment of psoriasis and other skin diseases
11/03/2004	EP1473047A1 Microbial cellulose wound dressing, containing PHMB, for treating chronic wounds
11/03/2004	EP1473019A1 Hair growth composition containing cork coal
11/03/2004	EP1472544A2 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
11/03/2004	EP1472377A2 Genetic polymorphisms in the preprotachykinin gene
11/03/2004	EP1472353A2 Group b streptococcus antigen
11/03/2004	EP1472341A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects
11/03/2004	EP1472273A2 Compositions and methods for the treatement of immune related diseases
11/03/2004	EP1472269A1 RNA INTERFERENCE MEDIATED INHIBITION OF INTERLEUKIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/03/2004	EP1472267A2 Rna interference mediated inhibition of protein tyrosine phosphatase type iva (prl3) gene expression using short interfering nucleic acid (sina)
11/03/2004	EP1472257A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
11/03/2004	EP1472255A1 Aza-arylpiperazines
11/03/2004	EP1472247A1 Antimicrobial thiadiazinone derivatives useful in treatment of bacterial infections
11/03/2004	EP1472245A2 Heteroaryl compounds useful as inhibitors of gsk-3
11/03/2004	EP1472244A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
11/03/2004	EP1472243A1 Piperidine derivatives and their use as antagonists of tachykinins
11/03/2004	EP1472241A1 Cytoprotective benzofuran derivatives

1 ... 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 ... 1065